Michael Kovochich

Dr. Michael Kovochich


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2021 in Environmental Science & Technology Letters
Verified
Journal Article
Open access
MKMichael Kovochich
Michael Kovochich
JPJillian A. Parker
Jillian A. Parker
SOSu Cheun Oh
Su Cheun Oh
JLJessica P. Lee
Jessica P. Lee
SWStephan Wagner
Stephan Wagner
KUKenneth M. Unice
Kenneth M. Unice
Tire and road wear particles (TRWPs) are generated from friction between tires and the road and contain polymer tread with pavement encrustations. Single particle analysis (SPA) of tire source contribution in environmental samples has been limited by interferences in common spectroscopic polymer techniques. This study extends a density separation and chemical mapping protocol for road simulator generated TRWPs toward the identification and characterization of individual TRWPs in more complex road dust, road-dust-spiked artificial sediment, tunnel dust, and environmental settling pond sediment samples. TRWPs were identified by a combination of physical (elongated/round shape with variable amounts of mineral encrustation) and elemental surface characteristics [co-localization of (S + Zn/Na) ± (Si, K, Mg, Ca, and Al)]. Organic surface markers (C7H7+), overlapping FTIR spectra with tread reference material, and resistance to heat-induced deformation were selectively used to confirm particle identification. The TRWP size displayed an increasing average trend of 54, 158, and 267 μm by number (94, 224, and 506 μm by volume) in tunnel dust, road dust, and environmental sediment, respectively. TRWP size distributions within road dust 10× diluted with artificial sediment agreed with those of pure road dust. Our SPA methodologies determined the size distribution of TRWPs in environmental sample types with increasing sample complexity.

1 July 2015 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
AMAmy K. Madl
Amy K. Madl
MLMonty Liong
Monty Liong
MKMichael Kovochich
Michael Kovochich
BFBrent L. Finley
Brent L. Finley
DPDennis J. Paustenbach
Dennis J. Paustenbach
GOGünter Oberdörster
Günter Oberdörster

1 July 2015 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
AMAmy K. Madl
Amy K. Madl
MKMichael Kovochich
Michael Kovochich
MLMonty Liong
Monty Liong
BFBrent L. Finley
Brent L. Finley
DPDennis J. Paustenbach
Dennis J. Paustenbach
GOGünter Oberdörster
Günter Oberdörster

5 March 2021 in Nanomaterials
Verified
Journal Article
Open access
PDF file
SMSharlee More
Sharlee More
MKMichael Kovochich
Michael Kovochich
TLTara Lyons-Darden
Tara Lyons-Darden
MTMichael Taylor
Michael Taylor
ASAlexandra Schulte
Alexandra Schulte
AMAmy K. Madl
Amy K. Madl
The exceptional physical and chemical properties of nickel nanomaterials have been exploited in a range of applications such as electrical conductors, batteries, and biomaterials. However, it has been suggested that these unique properties may allow for increased bioavailability, bio-reactivity, and potential adverse health effects. Thus, the purpose of this review was to critically evaluate data regarding the toxicity of oxidic nickel nanoparticles (nickel oxide (NiO) and nickel hydroxide (Ni(OH)2) nanoparticles) with respect to: (1) physico-chemistry properties; (2) nanomaterial characterization in the defined delivery media; (3) appropriateness of model system and translation to potential human effects; (4) biodistribution, retention, and clearance; (5) routes and relevance of exposure; and (6) current research data gaps and likely directions of future research. Inhalation studies were prioritized for review as this represents a potential exposure route in humans. Oxidic nickel particle size ranged from 5 to 100 nm in the 60 studies that were identified. Inflammatory responses induced by exposure of oxidic nickel nanoparticles via inhalation in rodent studies was characterized as acute in nature and only displayed chronic effects after relatively large (high concentration and long duration) exposures. Furthermore, there is no evidence, thus far, to suggest that the effects induced by oxidic nickel nanoparticles are related to preneoplastic events. There are some data to suggest that nano- and micron-sized NiO particles follow a similar dose response when normalized to surface area. However, future experiments need to be conducted to better characterize the exposure–dose–response relationship according to specific surface area and reactivity as a dose metric, which drives particle dissolution and potential biological responses.

1 June 2021 in Regulatory Toxicology and Pharmacology
Verified
Journal Article
Open access
MKMichael Kovochich
Michael Kovochich
AMAndrew Monnot
Andrew Monnot
DKDaniel G. Kougias
Daniel G. Kougias
SMSharlee L. More
Sharlee L. More
JWJared T. Wilsey
Jared T. Wilsey
GEGary Eichenbaum
Gary Eichenbaum
Cobalt (Co) alloys have been used for over seven decades in a wide range of medical devices, including, but not limited to, hip and knee implants, surgical tools, and vascular stents, due to their favorable biocompatibility, durability, and mechanical properties. A recent regulatory hazard classification review by the European Chemicals Agency (ECHA) resulted in the classification of metallic Co as a Class 1B Carcinogen (presumed to have carcinogenic potential for humans), primarily based on inhalation rodent carcinogenicity studies with pure metallic Co. The ECHA review did not specifically consider the carcinogenicity hazard potential of forms or routes of Co that are relevant for medical devices. The purpose of this review is to present a comprehensive assessment of the available in vivo preclinical data on the carcinogenic hazard potential of exposure to Co-containing alloys (CoCA) in medical devices by relevant routes. In vivo data were reviewed from 33 preclinical studies that examined the impact of Co exposure on local and systemic tumor incidence in rats, mice, guinea pigs, and hamsters. Across these studies, there was no significant increase of local or systemic tumors in studies relevant for medical devices. Taken together, the relevant in vivo data led to the conclusion that CoCA in medical devices are not a carcinogenic hazard in available in vivo models. While specific patient and implant factors cannot be fully replicated using in vivo models, the available in vivo preclinical data support that CoCA in medical devices are unlikely a carcinogenic hazard to patients.

8 May 2017 in Journal of Biomedical Materials Research Part B: Applied Biomaterials
Verified
Journal Article
Closed access
PDF file
MKMichael Kovochich
Michael Kovochich
EFErnest S. Fung
Ernest S. Fung
EDEllen Donovan
Ellen Donovan
KUKenneth Unice
Kenneth Unice
DPDennis J. Paustenbach
Dennis J. Paustenbach
BFBrent L. Finley
Brent L. Finley